Home / Healthcare/ Sanofi tests three-in-one antibody to treat or prevent HIV

Sanofi tests three-in-one antibody to treat or prevent HIV

Comments / {{hitsCtrl.values.hits}} Views / Wednesday, 27 September 2017 00:00

London (Reuters): A three-pronged man-made antibody, created by French drugmaker Sanofi and U.S. scientists, could offer a new way to treat or prevent HIV, following successful tests in monkeys.

Plans are under way to try the so-called trispecific antibody in initial human trials before the end of 2018, potentially adding a new weapon in the fight against AIDS, assuming the product proves safe and effective.

If all goes well, the three-in-one antibody could be used either as a long-acting treatment or a vaccine, according to Sanofi Chief Scientific Officer Gary Nabel.

“There is certainly urgency for a vaccine and this could help fill that void,” he said in an interview. “But we need to do the clinical studies and let nature tell us what works.”

Anthony Fauci, director of the U.S. National Institute of Allergy and Infectious Diseases, whose experts collaborated on the project, described the new approach as “intriguing”.

Unlike naturally occurring antibodies, the laboratory-made ones hit multiple biological targets in a single product - a feature that is particularly valuable in fighting HIV, given the huge genetic diversity of viruses around the world.

After exposing 24 monkeys to two strains of a monkey form of HIV, researchers found the majority of those given a traditional antibody developed infection compared with none of those receiving the trispecific one.

The results were published in the journal Science on Wednesday.

Other experiments showed the novel antibodies were active against 99 percent of more than 200 diverse strains of HIV tested.

The ability of trispecific antibodies to hit three targets at once might also make them useful in fighting cancer, other infectious diseases and autoimmune diseases. A number of drug companies are already working with bispecific antibodies but a three-pronged approach takes things to the next level.

“This is the beginning of a technology platform that we could adapt to other diseases, so we will look carefully at that,” Nabel said.

Share This Article


1. All comments will be moderated by the Daily FT Web Editor.

2. Comments that are abusive, obscene, incendiary, defamatory or irrelevant will not be published.

3. We may remove hyperlinks within comments.

4. Kindly use a genuine email ID and provide your name.

5. Spamming the comments section under different user names may result in being blacklisted.


Today's Columnists

2018 could see the birth of a new religion in India, Lingayatism

Saturday, 24 March 2018

The year 2018 is likely to see the birth (or official recognition) of a new religion in India, adding to the six already in existence and recognised by law. It is Lingayatism, found mostly in the South Indian States and Maharashtra.

No Confidence motion – A desperate attempt against PM will be defeated

Saturday, 24 March 2018

Ranil Wickremesinghe, the most popular Prime Minister, has made fellow politicians nervous if he is allowed to continue.

Mr. Elections Commissioner, play with a straight bat please

Saturday, 24 March 2018

The orange embers still burning. The once-busy extraordinarily-long orange drapes washed and put on sagging lines as far as eyes can see. Scattered stones and boulders cleared and removed by the municipalities.

The no-confidence motion against Ranil will create further chaos

Friday, 23 March 2018

The Mahinda Rajapaksa-backed Joint Opposition yesterday submitted a no-confidence motion against Prime Minister Ranil Wickremesinghe

Columnists More